FIELD: chemistry.
SUBSTANCE: invention relates to a novel method of producing 5-chloro-3-(4-methylsulphonyl) phenyl-2-(2-methyl-5-pyridinyl)pyridine (Etoricoxib), involving oxidation of 5-chloro-3-(4-methylthio) phenyl-2-(2-methyl-5-pyridinyl)pyridine in presence of catalyst of oxidation and interphase transport catalyst to obtain Etoricoxib.
EFFECT: technical outcome is novel simple and efficient method of producing Etoricoxib-selective inhibitor of cyclooxygenase-2.
20 cl, 29 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC SUBSTANCES-GPR119 AGONISTS | 2017 |
|
RU2734500C2 |
| DISUBSTITUTED FURANONES, THIAZOLES AND PENTENONES AS INHIBITORS OF CYCLOOXYGENASE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT | 1994 |
|
RU2131423C1 |
| PYRIDOPYRROLIZINE AND PYRIDOINDOLIZINE DERIVATIVES | 2003 |
|
RU2342386C2 |
| NEW DISUBSTITUTED PHENYL PIPERIDINES/PIPERAZINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION | 2005 |
|
RU2366654C2 |
| THIAZOLOPYRIDINE DERIVATIVES AS GPR119 AGONISTS | 2017 |
|
RU2749111C2 |
| IMIDAZOPYRIDINE DERIVATIVE USED IN TREATMENT OF DIABETES | 2013 |
|
RU2648242C2 |
| INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR | 2013 |
|
RU2679130C2 |
| PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2128172C1 |
| ISOXAZOLINE DERIVATIVES AS ANTI-PARASITIC AGENTS | 2011 |
|
RU2551354C2 |
| DERIVATIVES OF THIOAMIDE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2245874C2 |
